That’s not the right interpretation, IMO. As you just posted in #msg-96103430, Actavis is pulling back in multiple regions—not just China—which is consistent with the commentary in #msg-96043132.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”